Monopar Therapeutics (MNPR) Net Equity Issued and Repurchased (2017 - 2025)
Monopar Therapeutics (MNPR) recorded Net Equity Issued and Repurchased of $544,800 in Q4 2025, down 46.0% from $1.01 million a year earlier.
Monopar Therapeutics (MNPR) Net Equity Issued and Repurchased (2017 - 2025) Analysis & Trends
For FY2025, Monopar Therapeutics reported Net Equity Issued and Repurchased of $565,171, down 86.6% from FY2024.
- Annual Net Equity Issued and Repurchased has a four-year compound annual growth rate of 138.5% (FY2021 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $4.2 million in FY2024 (+102.6%), $2.07 million in FY2023, $109,337 in FY2022 (+525.6%) and $17,478 in FY2021.
- Quarterly Net Equity Issued and Repurchased has ranged from -$1.00 in Q2 2024 to $3.19 million in Q1 2024 over the past five years.
- On a year-over-year basis, Net Equity Issued and Repurchased rose in two of the last four quarters, with growth averaging 85.0%.
- Per Business Quant, the preceding three quarters came in at $214.00 (Q3 2025), $4,710 (Q2 2025) and $15,447 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Monopar Therapeutics | 680.58 Mn | 398.81 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 544,800.00 |
| Sep 30, 2025 | 214.00 |
| Jun 30, 2025 | 4,710.00 |
| Mar 31, 2025 | 15,447.00 |
| Dec 31, 2024 | 1.01 Mn |
| Jun 30, 2024 | -1.00 |
| Mar 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 339,870.00 |
| Sep 30, 2023 | 254,910.00 |
| Jun 30, 2023 | 657,791.00 |
| Mar 31, 2023 | 821,625.00 |
| Dec 31, 2022 | 109,168.00 |
| Sep 30, 2022 | 128.00 |
| Jun 30, 2022 | 41.00 |
| Mar 31, 2021 | 17,478.00 |
| Sep 30, 2020 | -1.42 Mn |
| Jun 30, 2020 | 913,525.00 |
| Mar 31, 2020 | 508,044.00 |
| Dec 31, 2019 | 10.22 Mn |
| Dec 31, 2017 | 10,000.00 |
Monopar Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MNPR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "MNPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MNPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();